Work

Second cancer incidence in CLL patients receiving BTK inhibitors

Year: 2020

Type: article

Study design: Observational Study

Source: Leukemia

DOI: 10.1038/s41375-020-0987-6

Authors: David A. Bond, Ying Huang, James L. Fisher, Amy S. Ruppert, Dwight H. Owen, Erin M. Bertino, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, Samantha M. Jaglowski, Kami J. Maddocks, John C. Byrd, Jennifer A. Woyach

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W3044998544

FWCI: 4.588

Cites: 53

Cited by: 64

Related to: 10